SCHEMBL7820003

SCHEMBL7820003

COc1ccc(NCC2CC2)c(N)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 3/20 0.54
CNR2 P34972 3/20 0.44
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 2/20 0.42
THRB P10828 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
MCL1 Q07820 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CNR1 P21554 2/20 0.41
EGFR P00533 1/20 0.40
MCHR1 Q99705 1/20 0.39
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39
VCP P55072 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13728343 0.88 PTGER4 (0.45) PTGER4CNR2ALDH1A1MEN1MAPT
SCHEMBL9604228 0.79 PTGER4 (0.58) PTGER4ALDH1A1MAPTTHRBKDM4E
SCHEMBL13438721 0.78 PTGER4 (0.49) PTGER4CNR2MAPTCNR1
SCHEMBL11934861 0.78 PTGER4 (0.49) PTGER4CNR2MAPTCNR1
SCHEMBL8348984 0.78 ALDH1A1 (0.51) PTGER4ALDH1A1MEN1MAPTTHRB
SCHEMBL10321 0.77 ALDH1A1 (0.48) PTGER4ALDH1A1MAPTKDM4EMCL1
SCHEMBL11894146 0.77 PTGER4 (0.46) PTGER4ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL11894145 0.77 PTGER4 (0.46) PTGER4ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL12798695 0.77 PTGER4 (0.46) PTGER4ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL5697163 0.77 ALDH1A1 (0.50) PTGER4ALDH1A1MEN1MAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2705024-B1 Alkyne benzotriazole derivatives MERCK SHARP & DOHME (US) 2015-12-16 EP disclosed
US-9139576-B2 Aminomethyl biaryl benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-09-22 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8785481-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-8785482-B2 Cyclohexene benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-8772276-B2 Alkyne benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-08 US disclosed
US-20140088112-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2014-03-27 US disclosed
US-20140088150-A1 CYCLOHEXENE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2014-03-27 US disclosed
US-20140088151-A1 ALHYDROXYMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. 2014-03-27 US disclosed
EP-2705024-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES Merck Sharp & Dohme Corp. (US) 2014-03-12 EP disclosed
US-20140066443-A1 AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2014-03-06 US disclosed
WO-2012151139-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-11-08 WO disclosed
WO-2012151139-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-11-08 WO disclosed
WO-2012151138-A1 CYCLOHEXENE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-11-08 WO disclosed
WO-2012151136-A1 AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-11-08 WO disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-05-31 US disclosed
WO-2010141360-A1 BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088150-A1 CYCLOHEXENE BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 PTGER4 1396/4885CNR2 49/4885ALDH1A1 3085/4885
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 PTGER4 790/4885CNR2 66/4885ALDH1A1 3327/4885
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 PTGER4 790/4885CNR2 66/4885ALDH1A1 3327/4885
US-20140066443-A1 AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES GRM2, GRM3, GRIN2C PTGER4 1952/4885CNR2 92/4885ALDH1A1 2342/4885
US-20140088112-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRM3 PTGER4 1555/4885CNR2 65/4885ALDH1A1 1808/4885
US-20140088151-A1 ALHYDROXYMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRM3 PTGER4 2139/4885CNR2 85/4885ALDH1A1 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.